Horse /

Breed profile · FDA CVM July 2026 extract

Pura Raza Española (Andalusian) adverse-event record

Adverse-event filings for Pura Raza Española (Andalusian) (Horse) in the FDA Center for Veterinary Medicine openFDA extract. Browse horse breeds, reactions, and outcomes below.

#317 of 510
by report volume (all breeds)
32
FDA CVM reports on file
9.4%
death-coded share of reports
6
Anorexia - top reaction

How the 32 reports break down

By recorded gender -- every report on file for Pura Raza Española (Andalusian), no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 6 4.5 3 1.5 0 2018 2019 2020 2021 2022 2023 2024 2025 Reports filed Death-coded reports
Annual report volume for Pura Raza Española (Andalusian) drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Pura Raza Española (Andalusian) ranks #317 of 510 by total reports (32). Death-coded-share rank requires at least 50 reports. National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#317
This breed, reports of 510

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Pura Raza Española (Andalusian) has 32 reports now versus 32 in that prior snapshot: 0 the same number of (0.0%).

Report change
+0
Death-coded reports
+0
Death-coded share
+0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Pura Raza Española (Andalusian) changes

Total Reports

32

Below-median volume

Deaths Reported

3

of 32 reports

Death-coded share of reports

9.4%

9.4% death-coded

Avg Age at Report

11.2 yr

456.1 kg avg weight

Death-Coded Outcome Share

Pura Raza Española (Andalusian) death-coded reports 9.4%
Cross-breed median

9.4% of 32 pura raza española (andalusian) reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Average weight at time of report: 456.1 kg (1005.7 lbs)

Top Reported Reactions

Anorexia 6
Lack of efficacy - NOS 6
Diarrhoea 4
INEFFECTIVE, GASTRIC ULCER(S) 4
Colic 4

Most Referenced Drugs

Omeprazole 11
Pergolide Mesylate 5
Polysulfated Glycosaminoglycan 3
Equine Influenza Virus, Killed Virus + Equine Rhinopneumonitis Virus, Killed Virus 3
Omeprazole 37% Oral Paste 2

Outcome Breakdown

Recovered/Normal
15 (46.9%)
Outcome Unknown
9 (28.1%)
Ongoing
5 (15.6%)
Euthanized
2 (6.3%)
Died
1 (3.1%)

Gender Distribution

Male 23 (71.9%)
Female 7 (21.9%)
Unknown 2 (6.3%)

Reports by Year

Year Reports Trend
2013 1
2014 1
2015 4
2016 3
2017 1
2018 6
2019 4
2020 1
2021 1
2022 3
2023 1
2024 3
2025 3

Pura Raza Española (Andalusian): high death-coded share in the FDA CVM extract

Signature read: Pura Raza Española (Andalusian)'s 9.4% death-coded share is in the upper third of the ≥50-report cohort (median 4.8%). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Pura Raza Española (Andalusian) sits at #317 of 510 by report volume among all breeds and #31 of 55 among horse breeds, with 32 reports and 3 (9.4%) death-coded. Mean age at report: 11.2 years, average weight 456.1 kg (1005.7 lbs).

Top reported signs: Anorexia (6), Lack of efficacy - NOS (6), Diarrhoea (4). Most-referenced drug: Omeprazole (11 reports), followed by Pergolide Mesylate (5) and Polysulfated Glycosaminoglycan (3).

Outcome coding on 32 status-recorded reports is dominated by Recovered/Normal (46.9%). Annual submissions ranged 1-2,025 across 13 years on file.

Horse Breeds With a Similar Report Volume

Showing 6 of 54 horse breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

Two openFDA-derived peer sets for Pura Raza Española (Andalusian), both outside the Horse family so the neighborhoods are not species containment (the similar-volume list above stays within species).

What to do with this horse

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Pura Raza Española (Andalusian)?
There are 32 adverse event reports involving Pura Raza Española (Andalusian) in the FDA database, of which 3 were death-coded (9.4% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Pura Raza Española (Andalusian) ranks #317 of 510 by report volume among all breeds PlainBreed indexes (#31 of 55 among horse breeds).
Where does Pura Raza Española (Andalusian) sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Pura Raza Española (Andalusian) is #317 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Horse, it is #31 of 55. It has fewer than 50 reports, so it is outside the death-rate ranking cohort (≥50 reports). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Pura Raza Española (Andalusian)?
The most commonly reported adverse reactions for Pura Raza Española (Andalusian) are Anorexia (6 reports), Lack of efficacy - NOS (6 reports), Diarrhoea (4 reports), INEFFECTIVE, GASTRIC ULCER(S) (4 reports), Colic (4 reports).
What drugs are most frequently associated with Pura Raza Española (Andalusian) adverse events?
The drugs most frequently referenced in Pura Raza Española (Andalusian) adverse event reports are Omeprazole (11 reports), Pergolide Mesylate (5 reports), Polysulfated Glycosaminoglycan (3 reports), Equine Influenza Virus, Killed Virus + Equine Rhinopneumonitis Virus, Killed Virus (3 reports), Omeprazole 37% Oral Paste (2 reports).
What is the average age of Pura Raza Española (Andalusian) in adverse event reports?
The average age of Pura Raza Española (Andalusian) at the time of adverse event reports is 11.2 years, with an average weight of 456.1 kg (1005.7 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Pura Raza Española (Andalusian) (Horse), extract as of July 2026 extract. 32 reports · 3 death-coded (9.4% of reports, not a mortality rate) · #317 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →